Table I.
No infection |
Hospital (ICU)-acquired infection |
Co-infection on ICU admission |
|
---|---|---|---|
N=32 (%) | N=24 (%) | N=4 | |
Age (years) | 54 ±16 | 52 ± 16 | 50 ± 6 |
Male | 23 (72) | 13 (54) | 3 |
Body mass index (kg/m2) | 29.8 ± 4.9 | 30.6 ± 6.8 | 28.9 ± 2.6 |
Length of ICU stay (days) | 7.8 ± 6.1 | 29.2 ± 24.9 | 23.8 ± 25.8 |
Ventilation status | |||
Mechanically ventilated | 18 (56) | 23 (96) | 3 |
Mean ventilator-days | 8 ± 5 | 24 ± 22 | 20 ± 18 |
Mortality (at ICU discharge) | 10 (31) | 8 (33) | 1 |
Prescribed empiric antimicrobials | 26 (81) | 24 (100) | 4 |
Number of antimicrobial courses | 1 ± 1 | 5 ± 2 | 4 ± 2 |
Antimicrobial-resistant organisms | |||
VRE colonization | 4 (7) | 7 (13) | 0 |
CPE colonization | 1 (2) | 1 (2) | 1 (2) |
ESBL infection (UTI) | 0 | 3 (5) | 0 |
MRSA infection (VAP) | 0 | 1 (2) | 0 |
MRSA colonization | 0 | 1 (2) | 0 |
VRE, vancomycin-resistant enterococci; CPE, carbapenemase-producing Enterobacterales; ESBL, extended-spectrum beta-lactamase-producing Enterobacterales; MRSA, meticillin-resistant Staphylococcus aureus; UTI, urinary tract infection; VAP, ventilator-associated pneumonia.
Data presented as number of patients (%) or mean ± standard deviation.